TWI383800B - Toona sinensis extract and extracting method thereof - Google Patents

Toona sinensis extract and extracting method thereof Download PDF

Info

Publication number
TWI383800B
TWI383800B TW98140126A TW98140126A TWI383800B TW I383800 B TWI383800 B TW I383800B TW 98140126 A TW98140126 A TW 98140126A TW 98140126 A TW98140126 A TW 98140126A TW I383800 B TWI383800 B TW I383800B
Authority
TW
Taiwan
Prior art keywords
extract
alcohol
citron
water
extraction mixture
Prior art date
Application number
TW98140126A
Other languages
Chinese (zh)
Other versions
TW201117820A (en
Inventor
Sue Joan Chang
Tsung Chi Tsai
Wen Cheng Huang
Original Assignee
Univ Nat Cheng Kung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nat Cheng Kung filed Critical Univ Nat Cheng Kung
Priority to TW98140126A priority Critical patent/TWI383800B/en
Publication of TW201117820A publication Critical patent/TW201117820A/en
Application granted granted Critical
Publication of TWI383800B publication Critical patent/TWI383800B/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Description

香椿萃取物及其萃取方法Citron extract and its extraction method

本發明係關於一種香椿萃取物,特別係關於一種應用於調節血糖的香椿萃取物。The present invention relates to a citron extract, in particular to a citron extract for use in regulating blood sugar.

香椿(別名椿或椿樹,學名為Toona sinensis ),是一種楝科多年生落葉性喬本植物,原生於中國東南、西南至華北等地區,現已全球性地廣泛栽植。香椿側枝少,樹皮略白,全株具特殊氣味,且其嫩葉可食用又終年可採集,極具利用價值。Citron (alias 椿 or eucalyptus, scientific name Toona sinensis ) is a perennial deciduous hormonal plant native to southeast China, southwest to north China, and has been widely planted globally. There are few side branches, the bark is slightly white, the whole plant has a special smell, and its young leaves are edible and can be collected all year round, which is of great value.

由於香椿本身樹型優美,十分適於作為行道樹或觀賞樹種,其木材還可用於製作家具或建材。此外,民間自古就有流傳「食用香椿,不染雜病」的說法,而在傳統藥典中記載亦有記載食用香椿或將香椿入藥的各項好處,包含清熱解毒、健胃理氣及止血固精等,都透露了香椿在醫藥學上或保健食品上的發展潛力。另外,現代生物學的研究亦藉由分子或細胞實驗上的證據指出香椿在應用於癌症或腫瘤治療方面頗有療效,更加彰顯了栽植香椿在健康保健方面可提供的實用功效與經濟利益。Because the tree itself is beautiful, it is very suitable as a street tree or ornamental tree. Its wood can also be used to make furniture or building materials. In addition, since ancient times, there has been a saying that "food is good for chewing and not contaminated with miscellaneous diseases". In the traditional pharmacopoeia, there are also records of the benefits of eating cigarettes or using toon, including heat-clearing and detoxifying, stomach-smelling and hemostasis. Etc., both disclose the development potential of Shannon in medicine or health food. In addition, modern biological research has also shown through molecular or cellular experimental evidence that the use of camphor in cancer or tumor treatment is more effective, which further demonstrates the practical and economic benefits that can be provided by health care.

除應用於特定癌症的治療外,傳統作法或習知知識已有食用或飲用香椿以達成降低血糖的作法。然而,一般民眾飲用時僅是單純地以熱水沖泡香椿茶葉或香椿茶葉粉飲用。此種「香椿茶」不僅在香椿成分比例上難以定量,其對降低血糖,乃至於調節或舒緩代謝症候群(例如糖尿病癥狀發生前)及其後續所引發之病症的功效亦不顯著,更其作用機制亦缺乏任何科學理論的支持。另外,此種習知之香椿葉利用方式對香椿中調節血糖之活性成分的萃取亦十分有限,難以進一步調製為健康食品或醫藥組合物。In addition to the treatments used in certain cancers, traditional practices or customary knowledge have been used to consume or drink cigarettes to achieve a blood sugar lowering practice. However, the general public only drink hot tea brewed with camphor tea or camphor tea powder. This kind of "Cinnamon Tea" is not only difficult to quantify in the proportion of toon ingredients, but also has no significant effect on lowering blood sugar, and even regulating or soothing the symptoms of metabolic syndrome (such as before the onset of diabetes symptoms) and its subsequent symptoms. The mechanism also lacks the support of any scientific theory. In addition, such conventional methods of using citron leaves have limited extraction of active ingredients for regulating blood sugar in citron, and it is difficult to further prepare them into health foods or pharmaceutical compositions.

因此,如何提供一種香椿萃取物,其可藉由特定的製備方法萃取,以有效地取得香椿葉中的活性成分,並具有良好的血糖調節功能,已成為重要課題之一。Therefore, how to provide a citron extract which can be extracted by a specific preparation method to effectively obtain an active ingredient in citron leaves and has a good blood sugar regulating function has become one of important subjects.

有鑑於上述課題,本發明之目的為提供一種香椿萃取物,其可藉由特定的製備方法萃取,並具有良好的血糖調節功能。In view of the above problems, it is an object of the present invention to provide a citron extract which can be extracted by a specific preparation method and which has a good blood sugar regulating function.

本發明之另一目的則為提供一種製備香椿萃取物之方法,其可用於製備上述之香椿萃取物。Another object of the present invention is to provide a process for preparing a camphor extract which can be used to prepare the above-described camphor extract.

為達上述目的,依據本發明之一種香椿萃取物,是經由下列步驟所製備,包含將一香椿葉置於一含醇之水溶液中;以及萃取以得一醇萃取混合物。To achieve the above object, a citron extract according to the present invention is prepared by the following steps comprising: placing a citron leaf in an aqueous alcohol-containing solution; and extracting to obtain an alcohol extraction mixture.

依據本發明之香椿萃取物,在其製備步驟中,香椿葉是為香椿葉粉末或香椿葉碎片。在本發明之一實施例中,香椿葉是為一香椿嫩葉粉末。According to the citron extract of the present invention, in the preparation step, the citron leaf is a fragrant leaf powder or a fragrant leaf fragment. In one embodiment of the invention, the citron leaf is a fragrant green leaf powder.

依據本發明之香椿萃取物,在其製備步驟中,含醇之水溶液的醇含量體積百分比為70%至100%。在本發明之一實施例中,含醇之水溶液的醇含量體積百分比為70%。According to the citron extract of the present invention, in the preparation step, the alcohol-containing aqueous solution has an alcohol content percentage by volume of 70% to 100%. In one embodiment of the invention, the alcohol-containing aqueous solution has an alcohol content volume percentage of 70%.

在本發明之一實施例中,本發明之香椿萃取物的製備步驟更包含分離醇萃取混合物,以得一醇萃取液以及一醇萃取物。In one embodiment of the invention, the step of preparing the camphor extract of the present invention further comprises separating the alcohol extract mixture to obtain an alcohol extract and an alcohol extract.

在本發明之一實施例中,本發明之香椿萃取物的製備步驟更包含乾燥或濃縮處理醇萃取液。In one embodiment of the invention, the step of preparing the camphor extract of the present invention further comprises drying or concentrating the alcohol extract.

在本發明之一實施例中,本發明之香椿萃取物的製備步驟更包含取醇萃取物,以水於高溫高壓下萃取以得一水萃取混合物。In an embodiment of the present invention, the preparation step of the toon extract of the present invention further comprises taking an alcohol extract and extracting with water under high temperature and high pressure to obtain a water extraction mixture.

在本發明之一實施例中,本發明之香椿萃取物的製備步驟更包含分離水萃取混合物,以得一水萃取液。In one embodiment of the invention, the step of preparing the camphor extract of the present invention further comprises separating the water extraction mixture to obtain an aqueous extract.

在本發明之一實施例中,本發明之香椿萃取物的製備步驟更包含混合醇萃取液及水萃取液。In one embodiment of the present invention, the step of preparing the camphor extract of the present invention further comprises mixing the alcohol extract and the water extract.

依據本發明之香椿萃取物,其製備步驟中的醇萃取液及水萃取液之混合比例可為3:1至6:1。在本發明之一實施例中,上述之醇萃取液及水萃取液之體積混合比例為3:1。According to the citron extract of the present invention, the mixing ratio of the alcohol extract and the water extract in the preparation step may be from 3:1 to 6:1. In one embodiment of the present invention, the volume ratio of the above-mentioned alcohol extract and water extract is 3:1.

在本發明之一實施例中,本發明之香椿萃取物的製備步驟更包含分別乾燥或濃縮上述之醇萃取液及水萃取液,並加以混合。In an embodiment of the present invention, the step of preparing the camphor extract of the present invention further comprises separately drying or concentrating the above-mentioned alcohol extract and water extract, and mixing.

依據本發明之香椿萃取物,其製備步驟中的經乾燥或濃縮的醇萃取液及經乾燥或濃縮的水萃取液之混合比例為3:1至6:1。在本發明之一實施例中,上述之經乾燥或濃縮的醇萃取液及經乾燥或濃縮的水萃取液之體積混合比例為3:1。According to the citron extract of the present invention, the ratio of the dried or concentrated alcohol extract and the dried or concentrated water extract in the preparation step is from 3:1 to 6:1. In one embodiment of the invention, the volume ratio of the dried or concentrated alcohol extract and the dried or concentrated water extract is 3:1.

依據本發明之一種製備香椿萃取物之方法,包含將一香椿葉置於一含醇之水溶液中;以及萃取以得一醇萃取混合物。A method of preparing a camphor extract according to the present invention comprises placing a vanilla leaf in an aqueous alcoholic solution; and extracting to obtain an alcohol extract mixture.

依據本發明之一種香椿萃取物,其是應用於調節血糖,且經由下列步驟所製備,包含將一香椿葉置於一含醇之水溶液中;以及萃取以得一醇萃取混合物。A citron extract according to the present invention, which is used for regulating blood sugar, is prepared by the following steps, comprising: placing a citron leaf in an aqueous solution containing an alcohol; and extracting to obtain an alcohol extraction mixture.

承上所述,因依據本發明之一種香椿萃取物係以醇溶液作為萃取溶劑,得以有效地取得香椿葉中的活性成分。再者,利用本發明所揭露之製備步驟所得之香椿萃取物可具有較佳之血糖調節能力,適於進一步應用在保健食品甚至醫藥領域。As described above, since the camphor extract according to the present invention uses an alcohol solution as an extraction solvent, the active ingredient in the camphor leaves can be effectively obtained. Furthermore, the citron extract obtained by the preparation step disclosed in the present invention can have a better blood sugar regulating ability and is suitable for further application in health foods and even medical fields.

以下將參照相關圖式,說明依據本發明之一種香椿萃取物,其中相同的元件將以相同的參照符號加以說明。Hereinafter, a citron extract according to the present invention will be described with reference to the related drawings, wherein the same elements will be described with the same reference numerals.

圖1為本發明較佳實施例之一種香椿萃取物的製備步驟流程圖,同時亦為本發明較佳實施例之一種製備香椿萃取物之方法的步驟流程圖。請參考圖1所示,依據本發明之一種香椿萃取物,是經由下列步驟所製備,包含將一香椿葉置於一含醇之水溶液中(S10);以及萃取以得一醇萃取混合物A1(S20)。BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a flow chart showing the steps of preparing a citron extract according to a preferred embodiment of the present invention, and also a flow chart of the method for preparing a citron extract according to a preferred embodiment of the present invention. Referring to FIG. 1, a citron extract according to the present invention is prepared by the following steps, comprising: placing a citron leaf in an alcohol-containing aqueous solution (S10); and extracting to obtain an alcohol extraction mixture A1 ( S20).

於步驟S10中,香椿葉是由香椿(學名為Toona sinensis )上採集下來的葉片,其型式可例如但不限於一香椿葉粉末或一香椿葉碎片。在本實施例中,香椿葉是為一香椿葉碎片,其是由香椿嫩葉經研磨、或擣碎、或其他可達成相同目的之手段所得。因香椿葉碎片或粉末比完整的香椿葉片具有較高的表面積與體積比,可有效提高萃取效率。In step S10, the citron leaf is a leaf collected from the citron (scientific name Toona sinensis ), and the type thereof may be, for example but not limited to, a fragrant leaf powder or a fragrant leaf shard. In this embodiment, the citron leaves are fragrant scorpion leaf pieces which are obtained by grinding, or mashing, or other means for achieving the same purpose. Because the fragrant leaf fragments or powder have a higher surface area to volume ratio than the intact citron leaves, the extraction efficiency can be effectively improved.

在本實施例中,上述之含醇之水溶液中的醇類可例如但不限於甲醇、或乙醇、或丙醇、或異丙醇、或正丁醇、或異丁醇、或其任一組合;而含醇之水溶液較佳是為一含乙醇之水溶液。In this embodiment, the alcohol in the above alcohol-containing aqueous solution may be, for example but not limited to, methanol, or ethanol, or propanol, or isopropanol, or n-butanol, or isobutanol, or any combination thereof. The alcohol-containing aqueous solution is preferably an aqueous solution containing ethanol.

另外,為有效萃取香椿葉中之活性成分,在本實施例中,含醇之水溶液的醇含量佔總溶液的體積百分比為70%至100%;較佳地,醇含量佔總溶液的體積百分比為70%。In addition, in order to effectively extract the active ingredient in the citron leaves, in the present embodiment, the alcohol content of the alcohol-containing aqueous solution accounts for 70% to 100% by volume of the total solution; preferably, the alcohol content accounts for the volume percentage of the total solution. It is 70%.

於含醇之水溶液中萃取香椿葉的方法在實施上並無特別限制,主要是對位於含醇之水溶液中的香椿葉進行搖動、或晃動、或震盪、或其他任何類似之手段,以達成獲取含有香椿活性成分之醇萃取混合物A1之目的。需注意的是,不論是搖動、或晃動、或震盪、或其他任何類似之手段,皆可以利用手動、或半自動化、或自動化的方式進行,在實施上並無特別的限制。在本實施例中,適於達成上述目的之手段可例如但不限於以機器或儀器持續、或間歇、或週期性地搖動或晃動裝有含醇之水溶液及香椿葉的容器、或提供超音波於一段時間內對含醇之水溶液中的香椿葉進行震盪。The method for extracting the citron leaves in the alcohol-containing aqueous solution is not particularly limited in practice, and is mainly for shaking, shaking, or oscillating, or any other similar means for the citron leaves in the aqueous solution containing alcohol to achieve the acquisition. The purpose of the alcohol extraction mixture A1 containing the citron active ingredient. It should be noted that whether it is shaking, shaking, or oscillating, or any other similar means, it can be performed manually, or semi-automatically, or automatically, and there is no particular limitation on the implementation. In the present embodiment, means suitable for achieving the above object may be, for example but not limited to, continuously or intermittently or periodically shaking or shaking a container containing an aqueous solution containing alcohol and citron leaves, or providing ultrasonic waves by machine or instrument. The citron leaves in the aqueous solution containing alcohol are oscillated over a period of time.

因此,將香椿葉置於具有特定比例的含醇之水溶中,並加以萃取,可得醇萃取混合物A1。與習知直接以熱水沖泡香椿的作法相較,依據本發明所得之醇萃取混合物A1具有較高之香椿活性成分及較佳之血糖調節能力(進一步說明請參照實驗例2)。Therefore, the camphor leaves are placed in a specific proportion of an alcohol-containing water solution and extracted to obtain an alcohol extract mixture A1. The alcohol extraction mixture A1 obtained according to the present invention has a higher aroma active ingredient and a better blood sugar regulating ability than the conventional method of directly brewing the toon with hot water (for further explanation, please refer to Experimental Example 2).

請參考圖1所示,在本實施例中,於萃取以得醇萃取混合物A1之步驟S20後,更包含一分離醇萃取混合物A1,以得一醇萃取液A11以及一醇萃取物A12的步驟(S30)。於此步驟S30中,分離醇萃取混合物A1之方法可例如但不限於將醇萃取混合物A1進行離心,使醇萃取物A12沈澱而與醇萃取液A11分離;或是利用過濾的方式,來分離醇萃取物A12和醇萃取液A11。在本實施例中,係利用離心處理來分離醇萃取物A12和醇萃取液A11,醇萃取液A11為上清液,而醇萃取物A12為沈澱於容器底部或側壁之殘渣。另外,離心所使用之轉速及時間長短則可視實際實施情況進行調整,並無特別限制。Referring to FIG. 1 , in the present embodiment, after the step S20 of extracting the mixture A1 for alcohol extraction, a step of separating the alcohol extraction mixture A1 to obtain an alcohol extract A11 and an alcohol extract A12 is further included. (S30). In this step S30, the method for separating the alcohol extraction mixture A1 may be, for example, but not limited to, centrifuging the alcohol extraction mixture A1 to precipitate the alcohol extract A12 to be separated from the alcohol extract A11; or separating the alcohol by filtration. Extract A12 and alcohol extract A11. In the present embodiment, the alcohol extract A12 and the alcohol extract A11 are separated by centrifugation, the alcohol extract A11 is the supernatant, and the alcohol extract A12 is the residue deposited on the bottom or side wall of the vessel. In addition, the number of revolutions and the length of time used for centrifugation can be adjusted depending on the actual implementation, and is not particularly limited.

請參考圖1所示,在本實施例中,於得到醇萃取液A11以及醇萃取物A12之步驟S30後,更包含一取醇萃取物A12,以水於高溫高壓下萃取以得一水萃取混合物H1之步驟(S40)。詳細而言,在此步驟中,較佳是取醇萃取物,以水於溫度121℃且壓力為1kgw/cm2 之環境下作用10至30分鐘萃取以得一水萃取混合物H1。Referring to FIG. 1 , in the present embodiment, after the step S30 of obtaining the alcohol extract A11 and the alcohol extract A12, an alcohol extract A12 is further included, and the water is extracted under high temperature and high pressure to obtain a water extraction. The step of the mixture H1 (S40). Specifically, in this step, it is preferred to take an alcohol extract and extract it with water at a temperature of 121 ° C and a pressure of 1 kgw / cm 2 for 10 to 30 minutes to obtain a water-extraction mixture H1.

請參考圖1所示,在本實施例中,於以水於高溫高壓下萃取以得水萃取混合物H1的步驟S40後,更包含一分離水萃取混合物H1,以得一水萃取液H11之步驟(S50)。於步驟S50中,分離水萃取混合物H1所使用之方法、及/或設定條件、及/或器械皆可參考步驟S30中之醇萃取混合物A1的分離,於此不再贅述。需注意的是,實施上仍亦注意醇及水之間的差異而再進行適當調整。Referring to FIG. 1 , in the present embodiment, after the step S40 of extracting the mixture H1 with water under high temperature and high pressure, the step of extracting the mixture H1 with water is further included to obtain a water extract H11. (S50). In the step S50, the method for separating the water extraction mixture H1, and/or the setting conditions, and/or the device may refer to the separation of the alcohol extraction mixture A1 in the step S30, and details are not described herein again. It should be noted that the implementation still pays attention to the difference between alcohol and water and then make appropriate adjustments.

請參考圖1所示,在本實施例中,於得到水萃取液H11的步驟S50後,更包含一分別乾燥或濃縮醇萃取液A11及水萃取液H11,並加以混合之步驟(S60)。藉由步驟S60處理,可得一經乾燥或濃縮的醇萃取液及一經乾燥或濃縮的水萃取液。於步驟S60中,乾燥或濃縮處理醇萃取液A11及水萃取液H11之方法可例如但不限於蒸發處理(evaporation)、或冷凍乾燥處理(lyophilization)、或噴霧乾燥處理(spray-drying)、加熱濃縮、或其任一組合。在本實施例中,是以冷凍乾燥處理醇萃取液A11及水萃取液H11。然而,需特別強調的是,對醇萃取液A11及水萃取液H11之乾燥或濃縮處理並非一定要完全乾燥或將所含之液體完全去除,可視實際需要有所調整,就意義上而言,乃是在將萃取液中的液體比例於此固液相混合物中所佔之整體比例降低。換言之,經乾燥或濃縮的醇萃取液及經乾燥或濃縮的水萃取液可以不同形式存在,例如乾燥之粉末或結晶、或未完全乾燥之粉末、或稠狀液體、或濃縮之醇萃取液A11及水萃取液H11。Referring to FIG. 1, in the present embodiment, after the step S50 of obtaining the aqueous extract H11, a step (S60) of separately drying or concentrating the alcohol extract A11 and the water extract H11 and mixing them is further included. By treatment in step S60, a dried or concentrated alcoholic extract and a dried or concentrated aqueous extract are obtained. In step S60, the method of drying or concentrating the alcohol extract A11 and the water extract H11 may be, for example but not limited to, evaporation, or lyophilization, or spray-drying, heating. Concentrated, or any combination thereof. In the present embodiment, the alcohol extract A11 and the water extract H11 were treated by freeze drying. However, it is particularly emphasized that the drying or concentration treatment of the alcohol extract A11 and the water extract H11 does not have to be completely dried or the liquid contained therein is completely removed, which may be adjusted according to actual needs, in the sense that This is because the proportion of the liquid in the extract is reduced in the overall proportion of the solid-liquid mixture. In other words, the dried or concentrated alcoholic extract and the dried or concentrated aqueous extract may be present in various forms, such as a dried powder or crystallization, or an incompletely dried powder, or a viscous liquid, or a concentrated alcoholic extract A11. And water extract H11.

此外,為使本發明之香椿萃取物具有更好的作用活性,於步驟S60中,經乾燥或濃縮的醇萃取液及經乾燥或濃縮的水萃取液的混合比例可為3:1至6:1。在本實施例中,混合比例為3:1。經混合後可得一具有較佳之香椿活性成分利用功效之混合的香椿萃取物M。Further, in order to make the camphor extract of the present invention have a better action activity, the mixing ratio of the dried or concentrated alcohol extract and the dried or concentrated water extract may be 3:1 to 6 in step S60: 1. In this embodiment, the mixing ratio is 3:1. After mixing, a citron extract M having a better blending effect of the active ingredients of the citron is obtained.

然而,需再次強調的是,雖經由上述步驟S10至S60可得最佳之本發明之香椿萃取物(進一步說明請參照實驗例2),但並非限制本發明之香椿萃取物必得經過此些步驟才得以完成。反之,只要在步驟S10及步驟S20執行後,取自本發明較佳實施例所揭示之步驟S30至步驟S60進行中或完成後、或取自步驟S30至步驟S60進行中或完成後並再加以一或數個步驟處理所得之萃取液、或混合液、或混合物或其任一組合,亦涵蓋於本發明所揭示之香椿萃取物的範圍內。以下將例舉以茲說明。However, it should be emphasized again that although the best extract of the citron extract of the present invention can be obtained through the above steps S10 to S60 (for further explanation, please refer to Experimental Example 2), it is not limited to the steps of the citron extract of the present invention. It was completed. On the contrary, after the steps S10 and S20 are performed, the steps S30 to S60 disclosed in the preferred embodiment of the present invention are performed in the middle or after the completion, or from the step S30 to the step S60, or after the process is completed. The resulting extract, or mixture, or mixture, or any combination thereof, in one or several steps is also encompassed within the scope of the extracts of the present invention. The following will be exemplified.

請參考圖1所示,在本實施例之另一態樣中,於得到醇萃取液A11以及醇萃取物A12之步驟S30後,可更包含一乾燥或濃縮處理醇萃取液A11的步驟(S41)。於步驟S41中,乾燥或濃縮處理的方式是與步驟S60中所述之乾燥或濃縮處理方式相同,於此不再贅述。經此步驟S41後同樣可得之經乾燥或濃縮的醇萃取液。然而,其雖與步驟S60中所得之經乾燥或濃縮的醇萃取液相同,但卻不需與其他萃取物或萃取液混合,而同樣具有較習知熱水沖泡的香椿茶為佳之活性功效。Referring to FIG. 1 , in another aspect of the embodiment, after the step S30 of obtaining the alcohol extract A11 and the alcohol extract A12, the step of drying or concentrating the alcohol extract A11 may be further included (S41). ). In the step S41, the drying or concentration treatment is the same as the drying or concentration treatment described in the step S60, and details are not described herein again. The dried or concentrated alcohol extract can also be obtained after this step S41. However, although it is the same as the dried or concentrated alcohol extract obtained in the step S60, it does not need to be mixed with other extracts or extracts, and the tea powder which is similar to the conventional hot water brewing is preferably active. .

同樣地,請參考圖1所示,在本實施例之又一態樣中,於得到水萃取液H11的步驟S50後,更包含一混合醇萃取液A11及水萃取液H11之步驟(S61)。經步驟S61處理後可得一混合的萃取液,其亦為依據本發明所得之香椿萃取物的一種態樣,並同樣具有較習知熱水沖泡的香椿茶為佳之活性功效。當然,若為提高混合的萃取液中之香椿萃取物的活性功效,在本實施例中,醇萃取液A11及水萃取液H11之混合比例可為3:1至6:1,而較佳的混合比例為3:1。Similarly, referring to FIG. 1 , in another aspect of the embodiment, after the step S50 of obtaining the water extract H11, the step of further mixing the alcohol extract A11 and the water extract H11 (S61) . After the step S61, a mixed extract can be obtained, which is also a kind of the extract of the camphor extract obtained according to the present invention, and also has the active effect of the hot tea brewed with the known hot water. Of course, in order to increase the activity of the extract of the camphor extract in the mixed extract, in the present embodiment, the mixing ratio of the alcohol extract A11 and the water extract H11 may be from 3:1 to 6:1, and preferably. The mixing ratio is 3:1.

綜上所述,因依據本發明之一種香椿萃取物係以醇溶液作為萃取溶劑,以有效地取得香椿葉中的活性成分。再者,利用本發明所揭露之製備步驟所得之香椿萃取物可具有較佳之血糖調節能力,適於進一步應用在保健食品甚至醫藥領域。另外,於實施例中,在萃取後按照特定比例將所得的產物混合,還可增加香椿萃取物中活性成分之效果。In summary, a citron extract according to the present invention uses an alcohol solution as an extraction solvent to effectively obtain an active ingredient in citron leaves. Furthermore, the citron extract obtained by the preparation step disclosed in the present invention can have a better blood sugar regulating ability and is suitable for further application in health foods and even medical fields. Further, in the examples, the obtained products are mixed in a specific ratio after the extraction, and the effect of the active ingredients in the camphor extract can also be increased.

本發明亦揭露之一種香椿萃取物,係應用於調節血糖,且此香椿萃取物是經由下列步驟所製備,包含將一香椿葉置於一含醇之水溶液中;以及萃取以得一醇萃取混合物。The present invention also discloses a citron extract for regulating blood sugar, and the citron extract is prepared by the following steps, comprising: placing a citron leaf in an aqueous solution containing alcohol; and extracting to obtain an alcohol extraction mixture. .

此外,本發明又揭露一種香椿萃取物,應用於增加過氧化小體增殖激活受體-γ(peroxisome proliferators activated receptor-gamma,PPAR-γ)之活性,且此香椿萃取物是經由下列步驟所製備,包含將一香椿葉置於一含醇之水溶液中;以及萃取以得一醇萃取混合物。由於上述兩種香椿萃取物之製備方法中所使用的手段、及/或方式、及/或溶液、及/或器械皆與前述所例舉之實施例中說明的手段、及/或方式、及/或溶液、及/或器械相同,於此不再贅述。In addition, the present invention further discloses a citron extract which is applied to increase the activity of peroxisome proliferators activated receptor-gamma (PPAR-γ), and the citron extract is prepared through the following steps. , comprising placing a citron leaf in an aqueous solution containing alcohol; and extracting to obtain an alcohol extraction mixture. The means, and/or manner, and/or the solution, and/or the apparatus used in the preparation method of the above two kinds of toona sinensis extracts, and the means and/or manners described in the above-exemplified examples, and / or the solution, and / or the device is the same, and will not be described here.

在習知技術中,已知過氧化小體增殖激活受體-γ的活化具有可增強細胞對胰島素的敏感度之功效,並可藉此機轉降低血糖濃度。而本發明所揭露之香椿萃取物則證實具有提高過氧化小體增殖激活受體-γ活性之能力(進一步說明請參照實驗例2),因此,本發明之香椿萃取物具有調製成為保健食品或飲品之潛力,並可依據所選用之萃取物態樣,例如乾燥粉末或萃取液,以本發明領域中之習知技術依據所需對萃取物進行固體或液體的調製或加工。另外,還可選擇性地包含適當的添加物/劑、及/或調味劑、及/或緩衝劑、及/或安定劑、及/或其他類似物,進而決定保健食品或飲品在香椿萃取物活性功效外的其他特徵。據此所得之保健食品或飲品,不僅具有較習知之香椿茶為佳的活性功效,更利於商品化及推廣使用。舉例來說,在本發明之一非限制性實施例中,在將本發明之香椿萃取物調製成為一口服液體狀製品時,所選用之安定劑為黃耆膠(tragacanth)、及/或阿拉伯膠(gum arabic)及/或明膠,至於選用之緩衝劑為檸檬酸鈉。In the prior art, it is known that the activation of peroxisome proliferator-activated receptor-γ has the effect of enhancing the sensitivity of cells to insulin, and can thereby reduce blood glucose concentration by machine. The extract of the citronella disclosed in the present invention has the ability to enhance the activity of the peroxisome proliferator-activated receptor-γ (for further explanation, please refer to Experimental Example 2), and therefore, the camphor extract of the present invention has a modulation into a health food or The potential of the beverage, and depending on the selected extract form, such as a dry powder or extract, can be solidified or processed in a solid or liquid form as desired in accordance with the teachings of the art in the art. In addition, a suitable supplement/agent, and/or flavoring agent, and/or buffer, and/or stabilizer, and/or the like may be optionally included to determine the health food or beverage in the camphor extract. Other characteristics than the active efficacy. The health food or drink obtained according to the present invention not only has better activity than the known citron tea, but also facilitates commercialization and popularization. For example, in one non-limiting embodiment of the invention, when the citron extract of the present invention is formulated into an oral liquid preparation, the stabilizer used is tragacanth, and/or arabic. Gum arabic and / or gelatin, as the buffer used is sodium citrate.

本發明另揭露一種用於調節血糖之香椿萃取物之醫藥組合物,包含一有效量之香椿萃取物,其是選自於上述實施例之各態樣中之任一香椿萃取物。此外,所述之醫藥組合物可更包含一醫藥學上可接受之載劑。其中,所述之「載劑」一詞包含任何本發明技術領域中習知的載劑,而可例如但不限於水、或生理食鹽水、或甘油、或有機溶劑、或安定劑、或螯合劑、或稀釋劑、或防腐劑、或乳化劑、或懸浮劑、或凝膠劑、或脂質體等。另外,在本發明之一實施例中,所述之醫藥組合物更包含一賦形劑。據此,此醫藥組合物得以製備成為一口服固體狀製劑,其類型包括錠劑、或經包覆的錠劑、或顆粒、或粉末、或膠囊、或其他相似者。The invention further discloses a pharmaceutical composition for regulating blood sugar of a camphor extract comprising an effective amount of a camphor extract selected from any of the various extracts of the above embodiments. Furthermore, the pharmaceutical composition may further comprise a pharmaceutically acceptable carrier. Wherein, the term "carrier" includes any carrier conventional in the art, and may be, for example but not limited to, water, or physiological saline, or glycerin, or an organic solvent, or a stabilizer, or a chelate. Mixtures, or diluents, or preservatives, or emulsifiers, or suspensions, or gels, or liposomes, and the like. Additionally, in one embodiment of the invention, the pharmaceutical composition further comprises an excipient. Accordingly, the pharmaceutical composition is prepared as an oral solid preparation of the type comprising a troche, or a coated lozenge, or granules, or a powder, or a capsule, or the like.

再者,除了適合於口服投予之外,本發明所揭露之醫藥組合物亦可依據本發明領域中之習知技術製備成為透過非經腸胃道、或注射、或局部使用等途徑進行投予之醫藥組合物。Furthermore, in addition to being suitable for oral administration, the pharmaceutical compositions disclosed herein can also be prepared by parenteral, injection or topical administration according to conventional techniques in the art of the present invention. Pharmaceutical composition.

以下將列舉數個實驗例以說明依本發明較佳實施例之香椿萃取物的製備步驟及其提高過氧化小體增殖激活受體-γ活性之功效。Several experimental examples will be enumerated below to illustrate the preparation steps of the camphor extract according to the preferred embodiment of the present invention and the effect of increasing the activity of the peroxisome proliferator-activated receptor-gamma.

實驗例1.香椿萃取物之製備步驟Experimental Example 1. Preparation steps of Toona sinensis extract

下述將以一實驗例說明本發明之香椿萃取物之一種製備步驟。A preparation step of the camphor extract of the present invention will be described below by way of an experimental example.

取一公斤的香椿嫩葉碎片浸泡於10公升的70%乙醇溶液中,再於室溫下以150rpm震盪萃取香椿嫩葉碎片10小時,以得醇萃取混合物A1。以10,000Xg離心醇萃取混合物A1約20分鐘後,可將醇萃取液A11(上清液)及醇萃取物A12(香椿嫩葉殘渣)分離。將離心分離後之醇萃取物A12再加入4公升的水,於溫度121℃且壓力為1kgw/cm2 之環境下萃取20分鐘,可得水萃取混合物H1,再以10,000Xg離心水萃取混合物H1約20分鐘,而藉此分離出水萃取液H11(上清液)。然後,分別對醇萃取液A11及水萃取液H11進行冷凍乾燥處理,得到經乾燥的醇萃取液及經乾燥的水萃取液。最後,將上述之經乾燥的醇萃取液及經乾燥的水萃取液依照3:1的比例混合而成為混合的香椿萃取物M1。One kilogram of the fragrant green leaf pieces was soaked in 10 liters of 70% ethanol solution, and the fragrant sage leaf pieces were shaken at 150 rpm for 10 hours at room temperature to obtain an alcohol extraction mixture A1. After extracting the mixture A1 at 10,000 x g for about 20 minutes, the alcohol extract A11 (supernatant) and the alcohol extract A12 (fragrant green leaf residue) were separated. The centrifuged alcohol extract A12 was further added to 4 liters of water, and extracted at a temperature of 121 ° C and a pressure of 1 kgw / cm 2 for 20 minutes to obtain a water extraction mixture H1, and then the mixture was extracted with 10,000 X g of centrifugal water. The aqueous extract H11 (supernatant) was separated by about 20 minutes. Then, the alcohol extract A11 and the water extract H11 are separately subjected to freeze-drying treatment to obtain a dried alcohol extract and a dried aqueous extract. Finally, the above dried alcohol extract and the dried aqueous extract were mixed in a ratio of 3:1 to form a mixed camphor extract M1.

實驗例2.香椿萃取物提高過氧化小體增殖激活受體-γ活性之試驗Experimental Example 2. Increasing the Peroxisome Activity of Peroxidase Promoting Receptor-γ Activity by Toona sinensis Extract

(一)細胞處理(a) cell processing

預先於12孔培養皿(12-well plate)中依細胞培養之習知技術培養人類肝癌細胞株(HepaG2細胞)。其後,每孔中置入溶液A及溶液B。其中,溶液A是為含有0.4μg載體pG5luc及0.2μg載體pBPPARγ之175μl不含胎牛血清之伊格爾式基本成分培養基(FBS free DMEM),而溶液B則是為含有4μg脂質體2000(lipofectamine 2000)之175μl不含胎牛血清之伊格爾式基本成分培養基。將溶液A及溶液B混合後靜置40分鐘(溶液A及溶液B在混合前是採個別配製之方式)。混合後之溶液A及溶液B,分別加入位於12孔培養皿中的細胞,並持續培養24小時,再依習知方式將培養基更換為正常之伊格爾式基本成分培養基,並再培養24小時。然後,分別在培養皿中的不同孔內加入皮利酮溶液(pioglitazone,一種藥物,可作為過氧化小體增殖激活受體-γ的結合物,具有活化過氧化小體增殖激活受體-γ之功效,可促進體內血糖代謝作用,從而降低血糖濃度)、或經熱水沖泡之香椿茶乾燥物(其是先以100℃的熱水沖泡香椿茶30分鐘後,離心取上清液,再經冷凍乾燥所得者)、或經乾燥或濃縮的醇萃取液之溶液、或經乾燥或濃縮的水萃取液之溶液、或混合的香椿萃取物M1之溶液,待於細胞培養箱內培養24小時後進行冷光分析。Human hepatoma cell lines (HepaG2 cells) were cultured in advance in a 12-well plate according to a conventional technique of cell culture. Thereafter, solution A and solution B were placed in each well. Among them, solution A is 175 μl of egg-free basic medium (FBS free DMEM) containing no fetal bovine serum containing 0.4 μg of carrier pG5luc and 0.2 μg of carrier pBPPARγ, and solution B is containing 4 μg of liposome 2000 (lipofectamine). 2000) 175 μl of Eagle's basic ingredient medium without fetal bovine serum. The solution A and the solution B were mixed and allowed to stand for 40 minutes (solution A and solution B were individually prepared before mixing). The mixed solution A and solution B were separately added to the cells in a 12-well culture dish, and cultured for 24 hours, and then the medium was changed to a normal Eagle-based basic medium by a conventional method, and cultured for another 24 hours. . Then, a piric acid solution (pioglitazone, a drug that acts as a conjugate of peroxisome proliferator-activated receptor-γ) with activated peroxisome proliferator-activated receptor-γ is added to each well in the culture dish. The effect can promote the metabolism of blood sugar in the body, thereby lowering the blood sugar concentration), or the dried tea of the camphor tea which is brewed by hot water (the first is to brew the camphor tea with hot water of 100 ° C for 30 minutes, then centrifuge to take the supernatant. , or lyophilized, or a solution of the dried or concentrated alcohol extract, or a solution of the dried or concentrated aqueous extract, or a mixed solution of the camphor extract M1, to be cultured in a cell culture incubator Cold light analysis was performed after 24 hours.

(二)冷光分析(Luminescence analysis)(2) Luminescence analysis

由於轉染(transfect)細胞所用之載體是以表現螢火蟲螢光素酶之基因作為報導基因(reporter gene),並其表現量受到過氧化小體增殖激活受體-γ活性調控。因此,利用本發明領域中之習知技術分析螢火蟲螢光素酶(firefly luciferase)的表現量可判定細胞內過氧化小體增殖激活受體-γ之活性強弱。The vector used for transfecting cells is a reporter gene expressing a firefly luciferase gene, and its expression is regulated by peroxisome proliferator-activated receptor-γ activity. Therefore, by analyzing the expression amount of firefly luciferase by the conventional technique in the field of the present invention, the activity of intracellular peroxisome proliferator-activated receptor-γ can be determined.

據此,分別於培養皿的各孔內加入250μl的細胞溶解緩衝液(cell lysis buffer)。待細胞充分溶解後,分別在各孔中取出10μl的細胞溶解液加入螢火蟲螢光素酶基質(firefly luciferase substrate)中。混合並待反應一段時間後,利用Mini-Lumat LB 9506測定儀偵測螢火蟲螢光素酶作用後所表現之冷光值;之後,再加入水母螢光素酶基質(Renilla luciferase substrate)偵測水母螢光素酶作用後所表現之冷光值。最後,以螢火蟲螢光素酶作用後所表現之冷光測定值除以水母螢光素酶作用後所表現之冷光測定值與空白控制組(未加入任何藥劑、或萃取液、或萃取物)之冷光測定值及正控制組(加入皮利酮達到濃度為0.1μg/ml)之冷光測定值進行比較,即可得知各香椿萃取液或萃取物活化過氧化小體增殖激活受體-γ的強弱差異。Accordingly, 250 μl of a cell lysis buffer was added to each well of the culture dish. After the cells were sufficiently dissolved, 10 μl of the cell lysate was taken out from each well and added to a firefly luciferase substrate. After mixing and reacting for a period of time, the luminescence value of the firefly luciferase was detected by a Mini-Lumat LB 9506 meter; then, the merion luciferase substrate was added to detect the jellyfish. The luminescence value exhibited by phototinase. Finally, the luminescence measurement value obtained by the action of firefly luciferase is divided by the luminescence measurement value expressed by the jellyfish luciferase and the blank control group (without adding any agent, extract, or extract) The cold light measurement value and the luminescence measurement value of the positive control group (with the addition of pirinone to a concentration of 0.1 μg/ml) were compared, and it was found that each citron extract or extract activated the peroxisome proliferator-activated receptor-γ. Strong and weak differences.

(三)結果分析(III) Analysis of results

將上述加入經熱水沖泡之香椿茶乾燥物、及經乾燥或濃縮的醇萃取液之溶液、及經乾燥或濃縮的水萃取液之溶液、及混合的香椿萃取物M1之溶液之各組分別進行與過氧化小體增殖激活受體-γ之活性有關的冷光測試。Adding the above-mentioned solution of the dried hot tea brewed camphor tea, and the dried or concentrated alcohol extract, and the dried or concentrated water extract solution, and the mixed camphor extract M1 solution Cold light tests related to the activity of peroxisome proliferator-activated receptor-gamma were performed separately.

圖2是為以不同濃度之混合的香椿萃取物M1之溶液處理後所表現的冷光強度,圖3是為以不同濃度之經乾燥或濃縮的水萃取液之溶液處理後所表現的冷光強度,圖4是為以不同濃度之經乾燥或濃縮的醇萃取液之溶液處理後所表現的冷光強度,以及圖5是為以不同濃度之經熱水沖泡之香椿茶乾燥物處理後所表現的冷光強度。請同時參考圖2至圖5,顯然地,依據本發明之香椿萃取物,不論是混合的香椿萃取物M1(圖2)、或經乾燥或濃縮的醇萃取液(圖3)、或經乾燥或濃縮的水萃取液(圖4)皆具有較熱水沖泡之香椿茶乾燥物(圖5)為佳的過氧化小體增殖激活受體-γ活化功效。若個別檢視之,圖2中混合的香椿萃取物M1係指經乾燥的醇萃取液及經乾燥的水萃取液依照3:1的比例混合而成,其活化過氧化小體增殖激活受體-γ的功效最佳,約相當於正控制組的110%。圖3中經乾燥或濃縮的水萃取液隨著劑量的提升而活化過氧化小體增殖激活受體-γ,最高約相當於正控制組(加入0.1μM之皮利酮)之40%以上的效果。而圖4中經乾燥或濃縮的醇萃取液活化過氧化小體增殖激活受體-γ之功效則又較經乾燥或濃縮的水萃取液為佳,約相當於正控制組之60%的效果。如圖5所示,至於習知以熱水沖泡之香椿茶乾燥物,則僅相當於正控制組之約40%左右的活化效果。值得一提的是,圖2中混合後的香椿萃取物M1則具有分別比經乾燥或濃縮的醇萃取液(圖3)及經乾燥或濃縮的水萃取液(圖4)較佳的效果。Figure 2 is the luminescence intensity exhibited by the solution of the mixed extract of the camphor extract M1 at different concentrations, and Figure 3 is the luminescence intensity exhibited by the solution of the dried or concentrated aqueous extract at different concentrations, Figure 4 is a graph showing the luminescence intensity of a solution of a dried or concentrated alcohol extract at different concentrations, and Figure 5 is a graph showing the treatment of dried citron tea with different concentrations of hot water. Cold light intensity. Referring also to Figures 2 to 5, it is apparent that the camphor extract according to the present invention, whether it is a mixed camphor extract M1 (Figure 2), or a dried or concentrated alcohol extract (Figure 3), or dried Or the concentrated water extract (Fig. 4) has a higher activity of the peroxisome proliferator-activated receptor-γ activation than the hot water brewed citron tea dry (Fig. 5). If examined individually, the mixed camphor extract M1 in Figure 2 means that the dried alcohol extract and the dried water extract are mixed in a ratio of 3:1, which activates the peroxisome proliferator-activated receptor- γ is the best, about 110% of the positive control group. The dried or concentrated aqueous extract in Figure 3 activates the peroxisome proliferator-activated receptor-gamma with increasing dose, up to about 40% of the positive control group (with 0.1 μM piricone). effect. The dried or concentrated alcohol extract in Figure 4 activates the peroxisome proliferator-activated receptor-γ, which is better than the dried or concentrated aqueous extract, which is equivalent to about 60% of the positive control group. . As shown in Fig. 5, as for the dried citron tea which is conventionally brewed with hot water, it is only equivalent to about 40% of the activation effect of the positive control group. It is worth mentioning that the mixed camphor extract M1 in Fig. 2 has better effects than the dried or concentrated alcohol extract (Fig. 3) and the dried or concentrated water extract (Fig. 4), respectively.

以上所述僅為舉例性,而非為限制性者。任何未脫離本發明之精神與範疇,而對其進行之等效修改或變更,均應包含於後附之申請專利範圍中。The above is intended to be illustrative only and not limiting. Any equivalent modifications or alterations to the spirit and scope of the invention are intended to be included in the scope of the appended claims.

A1...醇萃取混合物A1. . . Alcohol extraction mixture

A11...醇萃取液A11. . . Alcohol extract

A12...醇萃取物A12. . . Alcohol extract

H1...水萃取混合物H1. . . Water extraction mixture

H11...水萃取液H11. . . Water extract

M1...混合的香椿萃取物M1. . . Mixed toon extract

S10~S61...步驟S10~S61. . . step

圖1係本發明較佳實施例之一種香椿萃取物的製備步驟流程圖;以及1 is a flow chart showing the steps of preparing a camphor extract according to a preferred embodiment of the present invention;

圖2至圖5係以不同劑量之本發明之各香椿萃取物及習知之香椿茶乾燥物處理後所表現的冷光強度數據圖。Figures 2 to 5 are graphs showing the luminescence intensity data exhibited after treatment with various doses of the various extracts of the present scent and the dried citron tea of the present invention.

S10~S61...步驟S10~S61. . . step

Claims (19)

一種香椿萃取物,係經由下列步驟所製備,包含:將一香椿葉置於一含醇之水溶液中;萃取以得一醇萃取混合物;分離該醇萃取混合物,以得一醇萃取液以及一醇萃取物;以及取該醇萃取物,以水於高溫高壓下萃取以得一水萃取混合物。 A citron extract obtained by the following steps: placing a fragrant scented leaf in an aqueous alcohol solution; extracting to obtain an alcohol extraction mixture; separating the alcohol extraction mixture to obtain an alcohol extract and an alcohol The extract; and the alcohol extract is extracted with water at a high temperature and high pressure to obtain a water-extraction mixture. 如申請專利範圍第1項所述之香椿萃取物,其中該香椿葉係為香椿葉粉末或香椿葉碎片。 The citron extract according to claim 1, wherein the citron leaf is a fragrant leaf powder or a fragrant leaf fragment. 如申請專利範圍第1項所述之香椿萃取物,其中該含醇之水溶液之醇含量體積百分比為70%至100%。 The citron extract according to claim 1, wherein the alcohol-containing aqueous solution has an alcohol content percentage by volume of 70% to 100%. 如申請專利範圍第1項所述之香椿萃取物,更包含:分離該水萃取混合物,以得一水萃取液。 The citron extract according to claim 1, further comprising: separating the water extraction mixture to obtain an aqueous extract. 如申請專利範圍第4項所述之香椿萃取物,更包含:混合該醇萃取液及該水萃取液。 The citron extract according to claim 4, further comprising: mixing the alcohol extract and the water extract. 如申請專利範圍第5項所述之香椿萃取物,其中該醇萃取液及該水萃取液之混合比例為3:1至6:1。 The citron extract according to claim 5, wherein the alcohol extract and the water extract are mixed in a ratio of from 3:1 to 6:1. 如申請專利範圍第4項所述之香椿萃取物,更包含:分別乾燥或濃縮該醇萃取液及該水萃取液,並加以混合。 The citron extract according to claim 4, further comprising: separately drying or concentrating the alcohol extract and the water extract, and mixing. 如申請專利範圍第7項所述之香椿萃取物,其中該經乾燥或濃縮的醇萃取液及經乾燥或濃縮的該水萃取液之混合比例為3:1至6:1。 The citron extract according to claim 7, wherein the dried or concentrated alcohol extract and the dried or concentrated aqueous extract are mixed in a ratio of from 3:1 to 6:1. 一種香椿萃取物,係應用於調節血糖,且經由下列步驟所製備,包含:將一香椿葉置於一含醇之水溶液中;萃取以得一醇萃取混合物;分離該醇萃取混合物,以得一醇萃取液以及一醇萃取物;以及取該醇萃取物,以水於高溫高壓下萃取以得一水萃取混合物。 A citron extract for use in regulating blood sugar, and prepared by the following steps, comprising: placing a fragrant scented leaf in an aqueous solution containing alcohol; extracting to obtain an alcohol extraction mixture; separating the alcohol extraction mixture to obtain a An alcohol extract and an alcohol extract; and the alcohol extract is extracted with water at a high temperature and high pressure to obtain a water-extraction mixture. 一種香椿萃取物,應用於增加過氧化小體增殖激活受體-γ (PPAR-γ)之活性,係經由下列步驟所製備,包含:將一香椿葉置於一含醇之水溶液中;萃取以得一醇萃取混合物;分離該醇萃取混合物,以得一醇萃取液以及一醇萃取物;以及取該醇萃取物,以水於高溫高壓下萃取以得一水萃取混合物。A camphor extract for increasing the activity of a proliferator-activated receptor- gamma (PPAR-γ), which is prepared by the following steps, comprising: placing a vanilla leaf in an aqueous solution containing alcohol; extracting An alcohol extraction mixture is obtained; the alcohol extraction mixture is separated to obtain an alcohol extract and an alcohol extract; and the alcohol extract is taken and extracted with water under high temperature and high pressure to obtain a water-extraction mixture. 一種用於調節血糖之香椿萃取物之醫藥組合物,包含:一有效量之香椿萃取物,係選自申請專利範圍第1項至第8項中任一項。 A pharmaceutical composition for regulating blood sugar of a camphor extract, comprising: an effective amount of a camphor extract selected from any one of items 1 to 8 of the patent application. 一種製備香椿萃取物之方法,包含以下步驟:將一香椿葉置於一含醇之水溶液中;萃取以得一醇萃取混合物;分離該醇萃取混合物,以得一醇萃取液以及一醇萃取 物;以及取該醇萃取物,以水於高溫高壓下萃取以得一水萃取混合物。 A method for preparing a citron extract, comprising the steps of: placing a fragrant cilantro leaf in an aqueous alcohol solution; extracting to obtain an alcohol extraction mixture; separating the alcohol extraction mixture to obtain an alcohol extract and an alcohol extraction And taking the alcohol extract, extracting with water under high temperature and high pressure to obtain a water extraction mixture. 如申請專利範圍第12項所述之方法,其中該香椿葉係為香椿葉粉末或香椿葉碎片。 The method of claim 12, wherein the citron leaf is a fragrant leaf powder or a fragrant leaf fragment. 如申請專利範圍第12項所述之方法,其中該含醇之水溶液之醇含量體積百分比為70%至100%。 The method of claim 12, wherein the alcohol-containing aqueous solution has an alcohol content percentage by volume of from 70% to 100%. 如申請專利範圍第12項所述之方法,更包含:分離該水萃取混合物,以得一水萃取液。 The method of claim 12, further comprising: separating the water extraction mixture to obtain an aqueous extract. 如申請專利範圍第15項所述之方法,更包含:混合該醇萃取液及該水萃取液。 The method of claim 15, further comprising: mixing the alcohol extract and the water extract. 如申請專利範圍第16項所述之方法,其中該醇萃取液及該水萃取液之混合比例為3:1至6:1。 The method of claim 16, wherein the alcohol extract and the aqueous extract are mixed in a ratio of from 3:1 to 6:1. 如申請專利範圍第15項所述之方法,更包含:分別乾燥或濃縮該醇萃取液及該水萃取液,並加以混合。 The method of claim 15, further comprising: separately drying or concentrating the alcohol extract and the aqueous extract, and mixing. 如申請專利範圍第18項所述之方法,其中該經乾燥或濃縮的醇萃取液及經乾燥或濃縮的該水萃取液之混合比例為3:1至6:1。 The method of claim 18, wherein the dried or concentrated alcohol extract and the dried or concentrated aqueous extract are in a ratio of from 3:1 to 6:1.
TW98140126A 2009-11-25 2009-11-25 Toona sinensis extract and extracting method thereof TWI383800B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW98140126A TWI383800B (en) 2009-11-25 2009-11-25 Toona sinensis extract and extracting method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW98140126A TWI383800B (en) 2009-11-25 2009-11-25 Toona sinensis extract and extracting method thereof

Publications (2)

Publication Number Publication Date
TW201117820A TW201117820A (en) 2011-06-01
TWI383800B true TWI383800B (en) 2013-02-01

Family

ID=44935375

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98140126A TWI383800B (en) 2009-11-25 2009-11-25 Toona sinensis extract and extracting method thereof

Country Status (1)

Country Link
TW (1) TWI383800B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103301199B (en) * 2013-06-27 2015-08-19 广西大学 The method of comprehensive utilization of Tonnae Sinensis tender leaf

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1858045A (en) * 2005-05-06 2006-11-08 天津科技大学 Extracting method for Chinese toon old leaf flavone and saponin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1858045A (en) * 2005-05-06 2006-11-08 天津科技大学 Extracting method for Chinese toon old leaf flavone and saponin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Yang Y. C. et al.,"Enhancement of glucose uptake in 3T3-L1 adipocytes by Toona sinensis leaf extract." Kaohsiung J Med. Sci., 2003, vol. 19(7), pp. 327-332. *

Also Published As

Publication number Publication date
TW201117820A (en) 2011-06-01

Similar Documents

Publication Publication Date Title
KR20070111623A (en) Pharmaceutical composition for treating or preventing diabetic complication containing an extract of chinese herb as an effective ingredient
EA014234B1 (en) Composition for the treatment of hepatitis c or dietary supplement for prevention or alleviation hepatitis c symptoms
CN102283866A (en) Method for extracting propolis containing high-purity flavones
ES2719958T3 (en) Medicinal composition of seed extract of Emblica officinalis and method to prepare it
TWI661830B (en) An active substance ofmorchella, its use and a composition thereof for improving the reproductive function
KR20140137549A (en) A EXTRACTING METHOD Hovenia dulcis FOR ACTIVATING ALCOHOL METABOLISM AND RELIEVING A HANGOVER AND HEALTHY FUNCTIONAL FOOD CONTAINING THE SAME
CN109432315A (en) Application of the cogongrass rhizome extractive as active constituent in the product that preparation relieves fatigue
US20150125558A1 (en) Pleuropterus multiflorus extract and dipsacus asperoides extract for secreting insulin-like growth factor and promoting bone structure growth, and method for preparing same
WO2007007993A1 (en) Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea l. var. edulis extract
CN109985086B (en) Cyclocarya paliurus leaf instant powder and preparation method thereof
CN102321144A (en) Method for extracting ursolic acid from red jujube
TWI383800B (en) Toona sinensis extract and extracting method thereof
CN104758309B (en) The purposes of raspberry polysaccharide for reducing blood sugar
JP4743947B2 (en) Lipid metabolism improving composition
JPH06263648A (en) Promoter for lowering alcohol in body and its metabolite and refrigerant in mouth
CN103766901A (en) Application of andrographolide C to preparation of weight-losing food or medicine
US20180193401A1 (en) Anti-obesity composition comprising natural complex
US20100074975A1 (en) Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea L. Var. Edulis extract
CN102641342B (en) A kind of Chinese medicine extract and preparation method for the treatment of nephropathy
CN104435072B (en) A kind of extract and preparation method thereof with auxiliary hyperglycemic, reducing blood lipid
CN109619577A (en) The application of Rosa roxburghii Tratt water extract
KR20100101988A (en) Health care food silkworm hemolymph extract and process for preparing thereof
KR101703247B1 (en) A composition for healing a hangover comprising plant extracts
CN108815206B (en) Ganoderma extract for enhancing immunity
CN112675207B (en) Medicine suitable for protecting nerve cells and preparation and application thereof